188 related articles for article (PubMed ID: 34877075)
41. Guidelines of care for the management of cutaneous squamous cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
[TBL] [Abstract][Full Text] [Related]
42. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma.
Weisberg NK; Bertagnolli MM; Becker DS
J Am Acad Dermatol; 2000 Sep; 43(3):483-8. PubMed ID: 10954660
[TBL] [Abstract][Full Text] [Related]
43. [Cutaneous squamous cell carcinoma of the head and neck].
Deutsch J; Dippel E; Delank KW
Laryngorhinootologie; 2023 Mar; 102(3):186-193. PubMed ID: 36455599
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.
Karia PS; Han J; Schmults CD
J Am Acad Dermatol; 2013 Jun; 68(6):957-66. PubMed ID: 23375456
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of recurrent head and neck cutaneous squamous cell carcinoma.
Dean NR; Sweeny L; Magnuson JS; Carroll WR; Robinson D; Desmond RA; Rosenthal EL
J Skin Cancer; 2011; 2011():972497. PubMed ID: 21773040
[TBL] [Abstract][Full Text] [Related]
46. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
[TBL] [Abstract][Full Text] [Related]
47. Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.
Montuno MA; Brown B; Konda S; Motaparthi K
Dermatol Surg; 2018 Aug; 44(8):1057-1064. PubMed ID: 29746431
[TBL] [Abstract][Full Text] [Related]
48. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
49. AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery.
Zhao G; Kim KY; Zheng Z; Oh Y; Yoo DS; Lee ME; Chung KY; Roh MR; Jin Z
Oncol Lett; 2020 Mar; 19(3):2133-2140. PubMed ID: 32194711
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
Fania L; Didona D; Di Pietro FR; Verkhovskaia S; Morese R; Paolino G; Donati M; Ricci F; Coco V; Ricci F; Candi E; Abeni D; Dellambra E
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33572373
[TBL] [Abstract][Full Text] [Related]
51. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
[TBL] [Abstract][Full Text] [Related]
52. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
53. Medical treatment of advanced cutaneous squamous-cell carcinoma.
Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of mohs microgrpahic resection for cutaneous malignancy involving the scrotum.
Roberson D; Chelluri R; Skokan AJ; Xia L; Heavner MG; Lukowiak T; Schwartz L; Lee DJ; Guzzo TJ; Kovach SJ; Miller C; Kovell RC
Urol Oncol; 2021 Aug; 39(8):501.e11-501.e16. PubMed ID: 34187750
[TBL] [Abstract][Full Text] [Related]
56. Effective excision of cutaneous squamous cell carcinoma of the face using analysis of intra-operative frozen sections from the whole specimen.
Hutting KH; Bos PG; Kibbelaar RE; Veeger NJGM; Marck KW; Mouës CM
J Surg Oncol; 2018 Mar; 117(3):473-478. PubMed ID: 29073717
[TBL] [Abstract][Full Text] [Related]
57. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
Campoli M; Brodland DG; Zitelli J
J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872
[TBL] [Abstract][Full Text] [Related]
58. Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma.
Aboul-Fettouh N; Morse D; Patel J; Migden MR
Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021169S. PubMed ID: 34877077
[TBL] [Abstract][Full Text] [Related]
59. Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study.
Morelló-Vicente A; Espejo-Marín M; Oteiza-Rius I; Antoñanzas J; Vélez A; Salido-Vallejo R
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894404
[TBL] [Abstract][Full Text] [Related]
60. High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection?
Martinez JC; Cook JL
Dermatol Surg; 2007 Apr; 33(4):410-20. PubMed ID: 17430374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
